Santa Barbara startup seeks to end ‘energy poverty’
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
EyeClimate takes home top prize at 2024 New Venture Finals
For the last six years, Satish Kumar has been at UC Santa Barbara working on his Ph.D., including his thesis on methane detection emissions. For the past eight months, he has been putting that research and work into even more use, founding a company called EyeClimate. And all that work came to fruition on May 23 when Read More →
Cal Poly SBDC highlights AgTech company as ‘Business of the Year’
It has been a steady climb for San Luis Obispo-based TRIC Robotics. Originally founded in Idaho by CEO Adam Stager, TRIC decided to move to San Luis Obispo in large part because of Cal Poly University’s Center for Innovation and Entrepreneurship Small Business Development Center — a decision that has come to pay dividends. From Read More →
Netflix’s advertising platform plans include The Trade Desk
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Headphones blast Sonos into inner space
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen’s game-changing lung cancer treatment gains FDA approval
Thousand Oaks-based Amgen has received approval from the U.S. Food and Drug Administration for its treatment, Imdelltra, which is used on adult patients with extensive-stage small cell lung cancer with disease progression on or after platinum-based chemotherapy. Announced May 16, Amgen said in a press release that Imdelltra has received accelerated approval based on “encouraging Read More →
Arcutis treatment helps deliver Q1 earnings beat
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
